+49(0)2233 923749 contact@klaasconsulting.com

About us

we are medical devices consultants

Optimize Your Business Today!

Get A Free Consultation

Capitalize on our focus as medical device consultants.

Klaas consulting is a Sales and Marketing Consultancy for medical devices, dedicated to assisting medical devices companies – small and medium-sized (SME) – in entering or developing in the European market. We are networked across Europe and offer a full service guidance package – from Start to Growth.

Maria Klaas, the President and Owner, founded Klaas consulting in 2004. Maria has more than 25 years experience in the medical devices industry, and a successful career as a Sales and Marketing Director in internationally renowned medical devices companies, such as Abbott Diagnostics, Kimberly-Clark, SCA Hygiene Products and Hollister Corporation. Maria has a German University Degree in Business Administration and Marketing (MBA) and is certified as a Quality Manager by DGQ (German Association of Quality). She was project leader in „Customer Orientation“ and „Total Quality Management“ and trainer in Sales and Customer Orientation.

Beside her business, Maria is a business coach for start-up medical devices companies in an honorary capacity and participates in different medical technology and business networks across Germany.

Our team

Use our dynamic consultancy network working across Europe to support you in the marketing of your products.

Each of our consultants has extensive Marketing and Sales Management experience in top international medical devices companies. We have partners in all „key“ European markets for sales and marketing as well as further business advisory services.

Our network

We have network partners all over the world for our clients.

Worldwide Network – Sales and Marketing Professionals

photo: © iStock-metamorworks


„We enable SME medical devices companies to accelerate their entrance and development on the European Market with the best marketing and sales strategy.“


„We would like to be recognized as the leading European marketing and sales consultancy with the best customer-orientated reputation in all key industrial nations across the world for SME medical devices companies.“

Meet us in Duesseldorf or virtually 15-18 Nov. 21

Medica 2021 Duesseldorf

Latest Insights

  • Swissmedic refers to a leaflet on the obligations for authorised representatives, importers and distributors
  • European industry association for digital assistive technology DATEurope founded in early 2021. DAT includes aids for communication, for the blind and visually impaired, for environmental control, assistive call systems, software tools and robotics.
  • New web portal for the list of medical aids according to §139 SGB V of the GKV-Spitzenverband: for reference and online application
  • Revised guidance on "Designation of a Swiss authorised representative under the new MepV" of 29 January 2021, addressed to Swiss distributors and importers.
  • Overview of all assessments of new examination and treatment methods (NUB) by the G-BA
  • 22 Notified Bodies are now accredited. Currently (August 21) there are 4 in Italy, 2 in Finland, 3 in the Netherlands and 6 in Germany; in addition, one each in Slovakia, Hungary, Norway, France, Sweden, Ireland and Croatia. Nando database
  • the MHRA in the UK has published a guidance document for manufacturers and distributors of medical devices
  • BfArM included the first “apps on prescription” in the new directory for digital health applications (DiGA) in early October 2020
  • new standalone UKCA mark after Brexit; current EU CE marking will still be in operation for Medical Devices and invitro diagnostic in Great Britain until June 2023
  • EU-implementation regulation for the reprocessing of disposable products, valid from 26 May 2021
  • FDA increases medical device registration fees from October 2020
  • The European Commission published the new “Clinical evaluation assessment report template” of the Medical Devices Coordination Group (MDCG) on 17 July 2020
  • On 1 July 20, the Swiss Federal Council adopted the revision of the Regulation on Medical Devices (MepV) and the new Regulation on Clinical Trials for Medical Devices (KlinV-Mep). As a result, Switzerland remains subject to EU medical device law.
  • In-vitro-diagsnostics must be re-evaluated according to the new IVDR by 26 May 2022.
  • In future, the IVDR will also cover high-risk products that are manufactured and used in a single health facility, as well as genetic screening and tests for predisposing patients
  • The European Council postpones the application of EUDAMED by two years until May 2022